Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study

J. Sanyal, Arun; M. Younossi, Zobair; M Bass, N; Mullen, K.; Poordad, Fred; S. Brown, Robert; Vemuru, Ravikumar; Mazen Jamal, M.; Huang, Shirley; Merchant, Kunal; Bortey, Enoch; P. Forbes, William

doi:10.1111/j.1365-2036.2011.04808.x

Public

Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study

Published in Alimentary Pharmacology & Therapeutics • Aug 17, 2011

Authors:

Arun J. Sanyal

Zobair M. Younossi

N M Bass

Abstract

BACKGROUND: Hepatic encephalopathy (HE) is a brain disorder that often results from cirrhosis due to viral hepatitis, metabolic and alcohol-related liver disease, and is characterised by cognitive, psychiatric and motor impairments. Recurrent bouts of overt HE negatively impact daily functioning and...

Subject

Rifaximin

Medicine

Hepatic encephalopathy

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!